4[2] Aylward B., Lioyd J, zaffran M, et al, Reducing the risk of unsafe injection in immunization program: financial and oprational implications of various injection technologies. Bull. of the WHO, 1995, 73(4):531-540.
5[3] Hu DJ, Kane MA, Heymann DL. Transmission of HIV, hepatitis B virus and other blood-borne pathogen in health care setting: a review of risk factors and guidelines for prevention. Bull World Hcalth Organ, 1991, 69 (5):623-630.
6[4] Soeters R, Aus C. Hazards of injectable therapy. Trop Doct, 1989, 19 (3):124-126.
7[5] Aylward B, Kane M, McNair-Scott R, et al. Model-Based Estimates of the Risk of Human Immunodeficiency Virus and Hepatitis B Virus Transmission through Unsafe Injections. International Journal of Epidemiology, 1995, 24(2): 446-452.
8[6] Craig N. Shapiro, Occupatioonal Risk of injection with Hepatitis B and Hepatitis C virus. Surgical Clinic of North America, 1995, 75(6):1 056-1 057.
9[7] UNICEF. Fielden Battersby Analysts, Choosing a sustainable Policy for Giving Safe Injection in Romania, Final Report, October 1993.
10[8] Ko YC, Li SC, Yen YY, et al. Horizontal Transmission of Hepatitis B Virus from Siblings and Intermuscular Injection among Preschool Children in A Familial Cohort. Am J Epidemiol, 1991, 133(10): 1 015-1 023.
